What is an LP (Licensed Producer)?

A Licensed Producer (LP) is a cannabis company that holds a federal license from Health Canada to cultivate, process, and sell cannabis. Unlike the US market where cannabis remains federally illegal, Canada legalized recreational cannabis nationwide in October 2018 through the Cannabis Act, creating a regulated federal licensing framework.

LPs were the first publicly traded cannabis companies to gain significant investor attention, with many listing on the Toronto Stock Exchange (TSX) or NASDAQ beginning around 2017-2018. Companies like Tilray, Canopy Growth, Aurora Cannabis, and Cronos Group became household names during the cannabis boom, attracting billions in investment capital.

The LP business model differs fundamentally from US MSOs. LPs operate under a single federal license rather than a patchwork of state licenses. They can sell across all Canadian provinces (subject to provincial distribution agreements) and can export to international markets where medical cannabis is legal. Many LPs have expanded into Europe, Australia, and other markets.

However, the Canadian cannabis market has faced significant challenges since legalization. Oversupply drove prices down sharply, the illicit market retained a large share due to lower prices, and many provinces implemented restrictive retail licensing. These factors led to massive writedowns, restructuring, and in some cases bankruptcy among Canadian LPs.

For investors, LP stocks tend to trade at lower valuations than they did during peak hype but offer exposure to a legal, federally regulated market. Key metrics include international revenue diversification, cost per gram of production, inventory levels, and whether the company has achieved positive free cash flow. The best-positioned LPs have reduced costs, focused on premium brands, and built meaningful international businesses.